Literature DB >> 27349713

Biomarker development in osteosarcoma-Is there no longer any utility to tumor necrosis?

Patrick J Leavey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27349713     DOI： 10.1002/pbc.26125

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  2 in total

1.  Short-term and long-term prognostic value of histological response and intensified chemotherapy in osteosarcoma: a retrospective reanalysis of the BO06 trial.

Authors:  Eni Musta; Nan van Geloven; Jakob Anninga; Hans Gelderblom; Marta Fiocco
Journal:  BMJ Open       Date:  2022-05-10       Impact factor: 3.006

2.  Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models.

Authors:  Harish Babu Arunachalam; Rashika Mishra; Ovidiu Daescu; Kevin Cederberg; Dinesh Rakheja; Anita Sengupta; David Leonard; Rami Hallac; Patrick Leavey
Journal:  PLoS One       Date:  2019-04-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.